Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix PDT.

Trial Profile

Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix PDT.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Dec 2012

At a glance

  • Drugs Methyl aminolevulinate (Primary)
  • Indications Actinic keratosis
  • Focus Pharmacogenomic; Therapeutic Use
  • Sponsors Galderma
  • Most Recent Events

    • 22 Dec 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-001603-30).
    • 23 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Jun 2011 Planned end date changed from 1 Dec 2012 to 1 Oct 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top